Brain cancer Clinical Trials
Recruiting brain cancer studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat brain cancer. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting brain cancer studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting brain cancer trials
Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures
Asciminib With or Without Sildenafil for Brain Tumors
A Study Using Brain Stimulation and Behavioral Therapy to Increase Extent of Resection in Low-Grade Gliomas
B7-H3.CD28Z.CART in CNS Neoplasms
Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
DEXmedetomidine for Postoperative Analgesia and Delirium Prevention After NEUROsurgery (DEX-NEURO Trial)
Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer
Home-based Vision Rehabilitation Guided by Brain Imaging
Living Well With Brain Cancer: A Group-Based Intervention to Promote Whole-Person Well-Being
VorAsidenib With Lomustine In Patients With rEcurrent IDH-mutaNT Glioma Harboring IDH1 and/or IDH2 Mutations
Use of Shear Wave Elastography for Intraoperative Brain and Tumor Stiffness Measurements
Effect of Perioperative Ulinastatin on Postoperative Stroke in Patients With Brain Tumor
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Precision Radiotherapy Enabled by Molecular MRI
Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain
Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)
Safety and Effectiveness Evaluation of Temozolomide (Amitzo, NanoAlvand) in Patients With Grade III and IV Glioma Tumors
A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas
Observational Study of Responses to Treatments in Advanced Central Nervous System (CNS) Tumors
Home Transcranial Direct Current Stimulation (tDCS) to Enhance Functional Recovery
Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma
Measuring the Feasibility and Effect of a Virtual Reality Cognitive Training Intervention for Brain Cancer Survivors.
Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
C-SMART vs BE Well for Patients With Brain Tumors
A PROSPECTIVE, SINGLE-CENTERED, ASSESSOR-BLINDED STUDY TO EVALUATE THE CLINICAL EFFICACY OF THE PROPOSED CELL/TISSUE HISTOPATHOLOGY PROCESSOR CCELL (CONFOCAL FLUORESCENCE ENDOMICROSCOPY) FOR INTRAOPERATIVE DIAGNOSIS IN BRAIN TUMORS
Feasibility of Mask-Free Radiotherapy for Brain Tumor Patients
HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
Visual Plasticity Following Brain Lesions
Head-to-Head Evaluation of the Cancer Ontology Supervised Multimodal Orchestration (COSMO) AI System Versus Pathologist-Only Review
Multi-center Study on CCeLL-In Vivo's Clinical Efficacy for Intraoperative Brain Tumor Diagnosis.
Levetiracetam Prophylaxis in Brain Tumor Resection Pilot
The Use of 5-ALA in Paediatric Patients With High Grade Brain Tumours
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Brodalumab in the Treatment of Immune-Related Adverse Events
Brain Tumor Surgery and Postoperative Delirium
A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma
MICRO-BRAIN 2024: Study on Pediatric Brain Tumors
A Study of Sotorasib in People With Brain Tumors
Tracing Brain Tumors Through Deep Time
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients
Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)
TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas
Development of MRF for Characterization of Brain Tumors After Radiotherapy
18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery
The Effects of Intraoperative Tranexamic Acid on Perioperative Bleeding In Craniotomies
Genetic and Molecular Characterization of Nervous System Lesions
Lithium Treatment to Prevent Cognitive Impairment After Brain Radiotherapy
Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption
CONVIVO Endomicroscopy
Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders
Biological Collection of Brain Tumors
Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi)
Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
European Prospective Investigation Into Childhood Cancer
Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
Cognitive Training in the Virtual Reality Setting With Children Undergoing Radiotherapy for Brain Tumors
Brain cancer clinical trials — common questions
Are brain cancer clinical trials free to join?
Yes. Participating in a brain cancer clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a brain cancer clinical trial?
Each brain cancer study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a brain cancer trial near me?
Use the location controls above. We'll show recruiting brain cancer trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many brain cancer trials are recruiting right now?
We're currently tracking roughly 70 recruiting brain cancer trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.